<SEC-DOCUMENT>0001213900-20-004842.txt : 20200226
<SEC-HEADER>0001213900-20-004842.hdr.sgml : 20200226
<ACCEPTANCE-DATETIME>20200226171552
ACCESSION NUMBER:		0001213900-20-004842
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200214
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200226
DATE AS OF CHANGE:		20200226

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOSCIENCE, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				470883144
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38247
		FILM NUMBER:		20657104

	BUSINESS ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>f8k021320a1_aytubioscience.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FORM
8-K/A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date
of Report (Date of earliest event reported):&nbsp;<B>February 14, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AYTU
BIOSCIENCE, INC.<BR>
</B>(Exact name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>001-38247</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>47-0883144</B></FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction<BR>
    of incorporation)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File
    Number)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer <BR>
    Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>373
Inverness Parkway, Suite 206</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Englewood,
CO 80112</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Address
of principal executive offices, including Zip Code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Registrant&rsquo;s
telephone number, including area code: <B>(720) 437-6580</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>N/A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Former
name or former address, if changed since last report)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Check
the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications
    pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material
    pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 35%; border-bottom: black 1.5pt solid; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 28%; border-bottom: black 1.5pt solid; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    Symbol(s)</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 35%; border-bottom: black 1.5pt solid; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of each exchange on which registered</B></FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, par value $0.0001 per share</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AYTU</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    NASDAQ Stock Market LLC</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: right; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Emerging
growth company &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXPLANATORY NOTE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The signed consent of Hall &amp; Company, Innovus Pharmaceuticals,
Inc.&rsquo;s independent registered public accounting firm, was delivered prior to the filing of the Form 8-K, originally filed
on February&nbsp;14, 2020 (the &ldquo;Original Filing&rdquo;); however, the consent inadvertently omitted the consent to the incorporation
by reference of Hall &amp; Company&rsquo;s audit report &nbsp;relating to the consolidated financial statements of Innovus Pharmaceuticals,
Inc., appearing in the Annual Report on Form 10-K of Innovus Pharmaceuticals, Inc. for the years ended December 31, 2018 and 2017
into Aytu&rsquo;s registration statements. This amendment is being filed to update the consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This Form 8-K/A
does not modify, amend or update in any way any of the financial or other information contained in the Original Filing. This Form
8-K/A does not reflect events that may have occurred subsequent to the filing date of the Original Filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Item 9.01 Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><I>(a) Financial statements of businesses
acquired</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">The (i) audited consolidated financial statements
for Innovus Pharmaceuticals, Inc. as of and for the year-ended and December 31, 2018 and December 31, 2017 and (ii) unaudited consolidated
financial statements as of and for the nine months ended September 30, 2019 are incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(d)
The following exhibit is being filed herewith:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I></I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 91%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="f8k021320a1ex23-1_aytubio.htm">Consent of Hall &amp; Company relating to Innovus&rsquo; financial statements.</A></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1385818/000121390020004010/f8k021320_aytubioscience.htm">Current report on Form 8-K as filed on February 14, 2020</A></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">* Incorporated
by reference</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AYTU
    BIOSCIENCE, INC. </B></FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    26, 2020</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Joshua R. Disbrow</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joshua R. Disbrow</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>f8k021320a1ex23-1_aytubio.htm
<DESCRIPTION>CONSENT OF HALL & COMPANY RELATING TO INNOVUS' FINANCIAL STATEMENTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit 23.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We hereby consent to the incorporation by reference
in the Registration Statements (Form S-1 Nos 333-207421, 333-205414, 333-209874, 333-212100, 333-213489, 333-220351, Form S-3 Nos
333-221735, 333-235548, and Form S-8 No. 333-205462) of Aytu BioScience, Inc. of our report dated April 1, 2019, relating to the
consolidated financial statements of Innovus Pharmaceuticals, Inc., as of December 31, 2018 and 2017, which is incorporated by
reference in the Current Report on Form 8-K filed February 14, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">/s/ Hall &amp; Company Certified Public Accountants &amp; Consultants,
Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Irvine, CA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">February 26, 2020</P>



<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ @4# 2(  A$! Q$!_\0
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MZ'K]O\LZR^6Y'\0!R/T+#\:])KS?XA$ZSXET+0+8%YO,\V7'\"GU_ ,:,/\
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MS/3'X\4-K>EHMPSW]NJVPS,3( $&<9)^O'UH OT53GU;3[5PMQ>V\3$JH#R
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MQWSUK8\/Z?J.D^$8;&=('OH8F4"-SL=LG!R1QDG/MFKNNZDVD:+<WR1B1XP
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$ '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
